|
Jul 1
|
CARMAT Announces Its Placement in Receivership Procedure
|
|
Jul 1
|
Carmat files for insolvency amid cash crunch
|
|
Jun 30
|
French artificial heart maker Carmat files for insolvency
|
|
Jun 30
|
CARMAT Announces Filing Today for Insolvency and Requesting Being Placed in Receivership
|
|
Jun 25
|
CARMAT Announces Updates in Its Governance
|
|
Jun 13
|
CARMAT Announces the Start of the Equitization of the First Tranche of Its EIB Loan
|
|
Apr 24
|
CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024
|
|
Jan 15
|
CARMAT Achieves a Pivotal Year in 2023 by Reaching the Milestone of 50 Implants of the Aeson® Artificial Heart and Presents Its Development Prospects
|
|
Jan 12
|
CARMAT announces a conditional agreement in principle with the EIB on new loan repayment terms, as part of the management of its short-term financing challenge
|
|
Dec 28
|
CARMAT Announces a Software Enhancement Which Significantly Improves the Safety Profile of Its Aeson® Artificial Heart
|
|
Dec 4
|
CARMAT Announces the Opening of Its New Production Facility in Bois-d'Arcy, France
|